Published in Neuroimage Clin on July 06, 2013
Multi-delay Arterial Spin Labeling Application in Acute Ischemic Stroke | NCT05213793
Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med (2014) 3.27
Rapid 3D dynamic arterial spin labeling with a sparse model-based image reconstruction. Neuroimage (2015) 0.90
Postischemic hyperperfusion on arterial spin labeled perfusion MRI is linked to hemorrhagic transformation in stroke. J Cereb Blood Flow Metab (2015) 0.88
3D GRASE pulsed arterial spin labeling at multiple inflow times in patients with long arterial transit times: comparison with dynamic susceptibility-weighted contrast-enhanced MRI at 3 Tesla. J Cereb Blood Flow Metab (2014) 0.85
Optimization and reliability of multiple postlabeling delay pseudo-continuous arterial spin labeling during rest and stimulus-induced functional task activation. J Cereb Blood Flow Metab (2014) 0.84
The effects of hemodynamic lag on functional connectivity and behavior after stroke. J Cereb Blood Flow Metab (2015) 0.84
Arterial Spin Labeling Magnetic Resonance Imaging Estimation of Antegrade and Collateral Flow in Unilateral Middle Cerebral Artery Stenosis. Stroke (2016) 0.82
A neuroradiologist's guide to arterial spin labeling MRI in clinical practice. Neuroradiology (2015) 0.82
Increased hippocampal blood volume and normal blood flow in schizophrenia. Psychiatry Res (2015) 0.81
Inflow-vascular space occupancy (iVASO) reproducibility in the hippocampus and cortex at different blood water nulling times. Magn Reson Med (2015) 0.79
Characterizing Resting-State Brain Function Using Arterial Spin Labeling. Brain Connect (2015) 0.78
Signal changes on magnetic resonance perfusion images with arterial spin labeling after carotid endarterectomy. Surg Neurol Int (2016) 0.78
Three-dimensional acquisition of cerebral blood volume and flow responses during functional stimulation in a single scan. Neuroimage (2014) 0.76
Quantification of Serial Cerebral Blood Flow in Acute Stroke Using Arterial Spin Labeling. Stroke (2016) 0.75
Application of 3.0T magnetic resonance arterial spin labeling (ASL) technology in mild and moderate intracranial atherosclerotic stenosis. Exp Ther Med (2016) 0.75
Role of Genetic Variation in Collateral Circulation in the Evolution of Acute Stroke: A Multimodal Magnetic Resonance Imaging Study. Stroke (2017) 0.75
Quantitative measurement of blood flow in paediatric brain tumours-a comparative study of dynamic susceptibility contrast and multi time-point arterial spin labelled MRI. Br J Radiol (2016) 0.75
Patterns of postictal cerebral perfusion in idiopathic generalized epilepsy: a multi-delay multi-parametric arterial spin labelling perfusion MRI study. Sci Rep (2016) 0.75
Multi-delay ASL can identify leptomeningeal collateral perfusion in endovascular therapy of ischemic stroke. Oncotarget (2016) 0.75
Multiparametric estimation of brain hemodynamics with MR fingerprinting ASL. Magn Reson Med (2016) 0.75
Measuring functional connectivity in stroke: Approaches and considerations. J Cereb Blood Flow Metab (2017) 0.75
Intra-arterial high signals on arterial spin labeling perfusion images predict the occluded internal carotid artery segment. Neuroradiology (2017) 0.75
Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix. Magn Reson Med (2003) 3.44
Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling. Stroke (2000) 3.44
Arterial territories of the human brain: cerebral hemispheres. Neurology (1998) 2.47
Single-shot 3D imaging techniques improve arterial spin labeling perfusion measurements. Magn Reson Med (2005) 2.32
Arterial spin labeling in combination with a look-locker sampling strategy: inflow turbo-sampling EPI-FAIR (ITS-FAIR). Magn Reson Med (2001) 1.65
Applications of arterial spin labeled MRI in the brain. J Magn Reson Imaging (2012) 1.58
Minimizing acquisition time of arterial spin labeling at 3T. Magn Reson Med (2008) 1.53
Multiple inflow pulsed arterial spin-labeling reveals delays in the arterial arrival time in minor stroke and transient ischemic attack. AJNR Am J Neuroradiol (2010) 1.47
The value of arterial spin-labeled perfusion imaging in acute ischemic stroke: comparison with dynamic susceptibility contrast-enhanced MRI. Stroke (2012) 1.40
Reduced resolution transit delay prescan for quantitative continuous arterial spin labeling perfusion imaging. Magn Reson Med (2011) 1.29
Susceptibility contrast and arterial spin labeled perfusion MRI in cerebrovascular disease. J Neuroimaging (2003) 1.20
CBF measurements using multidelay pseudocontinuous and velocity-selective arterial spin labeling in patients with long arterial transit delays: comparison with xenon CT CBF. J Magn Reson Imaging (2012) 1.15
Arterial spin labeling perfusion MRI in pediatric arterial ischemic stroke: initial experiences. J Magn Reson Imaging (2009) 1.14
Whole-brain arterial spin labeling perfusion MRI in patients with acute stroke. Stroke (2012) 1.14
Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol (2006) 1.07
Arterial spin label imaging of acute ischemic stroke and transient ischemic attack. Neuroimaging Clin N Am (2011) 1.05
Comparison of arterial spin labeling and bolus perfusion-weighted imaging for detecting mismatch in acute stroke. Stroke (2012) 0.99
Periprocedural arterial spin labeling and dynamic susceptibility contrast perfusion in detection of cerebral blood flow in patients with acute ischemic syndrome. Stroke (2013) 0.91
Pseudocontinuous arterial spin labeling quantifies relative cerebral blood flow in acute stroke. Stroke (2012) 0.89
A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med (2013) 9.97
Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke (2008) 8.45
The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke (2007) 8.06
Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke (2005) 8.05
Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet (2012) 7.89
Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med (2013) 7.00
Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. Brain (2005) 6.81
The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia (2010) 6.23
Multiplexed echo planar imaging for sub-second whole brain FMRI and fast diffusion imaging. PLoS One (2010) 5.74
Transient ischemic attack--proposal for a new definition. N Engl J Med (2002) 4.94
Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA (2004) 4.82
Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme. J Clin Oncol (2010) 4.23
Statistical analysis of the primary outcome in acute stroke trials. Stroke (2012) 3.52
Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation (2011) 3.30
Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. J Clin Oncol (2011) 3.23
Brain morphology associated with obstructive sleep apnea. Am J Respir Crit Care Med (2002) 3.18
DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet Neurol (2011) 3.18
Mutations in a human ROBO gene disrupt hindbrain axon pathway crossing and morphogenesis. Science (2004) 3.01
Addition of brain and carotid imaging to the ABCD² score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Lancet Neurol (2010) 2.87
Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke (2003) 2.87
Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis. Ann Intern Med (2013) 2.87
Collateral flow predicts response to endovascular therapy for acute ischemic stroke. Stroke (2011) 2.80
Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke (2002) 2.76
MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke (2004) 2.75
Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke (2013) 2.66
Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol (2011) 2.62
CT and MRI early vessel signs reflect clot composition in acute stroke. Stroke (2011) 2.52
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50
Collateral blood vessels in acute ischaemic stroke: a potential therapeutic target. Lancet Neurol (2011) 2.46
Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ (2010) 2.42
Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. JAMA (2012) 2.38
Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Stroke (2007) 2.36
The smoking-thrombolysis paradox and acute ischemic stroke. Neurology (2005) 2.31
Late secondary ischemic injury in patients receiving intraarterial thrombolysis. Ann Neurol (2002) 2.31
Stroke declines from third to fourth leading cause of death in the United States: historical perspective and challenges ahead. Stroke (2011) 2.23
Efficacy of intra-arterial fibrinolysis for acute ischemic stroke: meta-analysis of randomized controlled trials. Stroke (2010) 2.17
Mechanical recanalization in basilar artery occlusion: the ENDOSTROKE study. Ann Neurol (2015) 2.16
Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke. Circulation (2010) 2.15
Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke (2003) 2.06
Effect of pre-diabetes on future risk of stroke: meta-analysis. BMJ (2012) 2.04
Indirect revascularization for nonmoyamoya intracranial arterial stenoses: clinical and angiographic outcomes. J Neurosurg (2012) 2.03
Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke. Circ Cardiovasc Qual Outcomes (2010) 2.02
Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke (2006) 2.02
Persistent metabolic crisis as measured by elevated cerebral microdialysis lactate-pyruvate ratio predicts chronic frontal lobe brain atrophy after traumatic brain injury. Crit Care Med (2008) 2.00
Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience. Epilepsia (2009) 1.99
Dispatcher recognition of stroke using the National Academy Medical Priority Dispatch System. Stroke (2009) 1.96
Prospective, multicenter, single-arm study of mechanical thrombectomy using Solitaire Flow Restoration in acute ischemic stroke. Stroke (2013) 1.94
Reduced neocortical thickness and complexity mapped in mesial temporal lobe epilepsy with hippocampal sclerosis. Cereb Cortex (2006) 1.87
Diffusion tensor imaging demonstrates brainstem and cerebellar abnormalities in congenital central hypoventilation syndrome. Pediatr Res (2008) 1.86
A midlife stroke surge among women in the United States. Neurology (2007) 1.86
Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke. Stroke (2014) 1.76
Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis. Stroke (2010) 1.75
Simultaneous ring voice-over-Internet phone system enables rapid physician elicitation of explicit informed consent in prehospital stroke treatment trials. Cerebrovasc Dis (2009) 1.71
Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging. Ann Neurol (2008) 1.71
Expanding indications for statins in cerebral ischemia: a quantitative study. Arch Neurol (2005) 1.69
Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke (2002) 1.68
Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy. J Neurooncol (2011) 1.67
Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke. Stroke (2011) 1.67
Acute stroke imaging research roadmap. Stroke (2008) 1.66
Risk score for in-hospital ischemic stroke mortality derived and validated within the Get With the Guidelines-Stroke Program. Circulation (2010) 1.66
Quantifying the value of stroke disability outcomes: WHO global burden of disease project disability weights for each level of the modified Rankin Scale. Stroke (2009) 1.63
Annual incidence of first silent stroke in the United States: a preliminary estimate. Cerebrovasc Dis (2003) 1.60
Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. Radiology (2003) 1.59
Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke (2006) 1.59
Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial. Radiology (2013) 1.55
Efficacy of folic acid supplementation in cardiovascular disease prevention: an updated meta-analysis of randomized controlled trials. Eur J Intern Med (2012) 1.55
Hydrophilic polymer emboli: an under-recognized iatrogenic cause of ischemia and infarct. Mod Pathol (2010) 1.55
Design and rationale of the Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy (MR RESCUE) Trial. Int J Stroke (2012) 1.55
Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke. Circ Cardiovasc Qual Outcomes (2012) 1.54
Body mass index and hospital discharge outcomes after ischemic stroke. Arch Neurol (2007) 1.54